![Lupin Launches Generic Joint Pain Drug In US Lupin Launches Generic Joint Pain Drug In US](https://c.ndtvimg.com/2022-12/abuc6l2_lupin-pharma_625x300_09_December_22.jpg)
Lupin’s product is the generic version of Pennsaid. (Representational)
New Delhi:
Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.
The company’s product — Diclofenac Sodium Topical Solution 2 per cent — is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
India’s Economy To Grow At 6.9% This Year: World Bank